13min chapter

Bloomberg Talks cover image

Eli Lilly CEO Dave Ricks Talks Weight Loss Drugs Success

Bloomberg Talks

CHAPTER

Innovations in Weight Loss Medications

This chapter explores the unexpected benefits of Exenetide, a diabetes drug that aids in weight loss, and compares it with terzepatide in terms of mechanisms and effectiveness. It highlights the alarming rise in obesity rates, the healthcare challenges surrounding weight loss medications, and the significant role of insurance in treatment accessibility. Additionally, the discussion addresses the threats posed by counterfeit drugs, ongoing research for oral alternatives, and the complexities of maintaining weight loss post-medication.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode